In CD45+ cells derived from RCC tissues, pathways associated with activated immune processes were up-regulated, including interleukin signaling, complement and coagulation cascades, and antimicrobial peptide response, as well as a distinct metabolic profile (pentose phosphate up-regulation) compared with NAT-derived CD45+ cells. Here, BRD2 is linked to renal cell carcinoma.